SEROPREVALENCE OF HEPATITIS C VIRUS AMONG HEPATITIS B VIRUS POSITIVE PATIENTS ATTENDING TO TALODI HOSPITAL, SOUTH KORDOFAN, STATE, SUDAN.

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2015, Vol 4, Issue 1

Abstract

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) share common mode of transmission and both are able to induce a chronic infection. Dual HBV/HCV chronic confection is a fairly frequent occurrence, especially in high endemic areas and among individuals at high risk of parenterally transmitted infections. The intracellular interplay between HBV and HCV has not yet been sufficiently clarified, also due to the lack of a proper in vitro cellular model. Dual HBV/HCV infection has been associated to a severe course of the liver disease and to a high risk of developing hepatocellular carcinoma. This study aimed to determine seroprevalence of hepatitis C IgG anti bodies among known hepatitis B infected patients. Methods: This is a cross sectional study included HBV infected patients aged between (11-54) years old with mean 30.4 years old conducted in Talodi Hospital, South Kordofan, State, Sudan, during February to May 2014. We performed HCV serum marker, was detected by using commercially available enzyme-linked immunosorbent assay (ELISA) kit. Generated data were analyzed by using SPSS program (version11) Results: HCV IgG Ab was detected only in 1 (1.1%)from patient, and he was male. The mean age of the studied group was (30.4) their age range (11-54) years. There were 63 men (70%) and 27 women (30%), (n = 90). Conclusion: The seropositivity of HCV was low, similar to study done in Umdurman Maternity Hospital.

Authors and Affiliations

Ikram Mustafa Altyeib Fadul| MSc.student – Al Neelain University, Faculty of Medical Laboratory Science, Sudan., Wafa Ibrahim Elhag| Associate professor, Faculty of Medical Laboratory Sciences, Al Neelain University, Sudan., Mokhtar Zakaria Adam Salih| Talodi hospital, Laboratory department, South Kordofan, State, Sudan.

Keywords

Related Articles

PREPARATION AND ASSESSMENT OF AMORPHOUS SOLID DISPERSIONS USING VARIOUS METHODOLOGIES

Amorphous products and particularly amorphous solid dispersions are currently one of the most upcoming and widely used areas in the pharmaceutical field. This approach offers huge potential and advantageous features rega...

FORMULATION DEVELOPMENT AND EVALUATION OF TABLETS CONTAINING ANOECTOCHILUS FORMOSANUS EXTRACT: PROCESS OPTIMISATION BY FULL FACTORIAL DESIGN

AnoectochilusformosanusHayata (Orchidaceae) is an indigenous and valuable Taiwanese medicinal plant and has been used popularly as a nutraceutical herbal tea in Taiwan and other Asian countries.The present research inves...

ASSOCIATION OF THYROID-STIMULATING HORMONE AND THYROID HORMONES, T3 AND T4 WITH LIPID PROFILE IN GHANAIAN NORMOTENSIVE PREGNANT WOMEN

Thyroid dysfunction during pregnancy is associated with various adverse perinatal and maternal outcomes. Evidence suggests that thyroid stimulating hormone (TSH) may exert extra-thyroidal effects and modify the profile o...

FORMULATION & CHARACTERIZATION OF TOPICAL GEL CONTAINING SANDALWOOD OIL OF NAPROXEN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

The present research study is based on development of a topical gel formulation of naproxen containing sandalwood oil. The oral administration of naproxen comes with potential gastrointestinal disorders which can be avoi...

RP-HPLC assay method development and validation of ketorolac and olopatidine in opthalmic liquid dosage forms

A simple reverse phase high performance liquid chromatographic assay method was developed and validated for the simultaneous estimation of Ketorolac and olopatadine in ophthalmic liquid dosage forms. The chromatographic...

Download PDF file
  • EP ID EP3502
  • DOI -
  • Views 418
  • Downloads 21

How To Cite

Ikram Mustafa Altyeib Fadul, Wafa Ibrahim Elhag, Mokhtar Zakaria Adam Salih (2015). SEROPREVALENCE OF HEPATITIS C VIRUS AMONG HEPATITIS B VIRUS POSITIVE PATIENTS ATTENDING TO TALODI HOSPITAL, SOUTH KORDOFAN, STATE, SUDAN.. Journal of Biomedical and Pharmaceutical Research, 4(1), 112-115. https://europub.co.uk/articles/-A-3502